Outcomes Of Cutaneous Indeterminate Dendritic Cell Tumors: Case Report And Pooled Analysis

The goal of this study was to investigate the prognostic impact of indeterminate dendritic cell tumors (IDCTS). Cases of cutaneous IDCT both in the literature and our reported case were collected and analyzed. With our patient, 65 cases of cutaneous IDCTs were evaluated. Median age of included cases was 48-year old. Patients with hematological neoplasia were 17-year older than non-hematological neoplasia group. Patients older than 60-year had significant lower overall survival (OS) rate than patients younger than 60-year (P=0.016). OS rate of hematological neoplasia patients was significantly lower than non-hematological neoplasia patients. In addition, histological feature of prominent nucleoli had significant higher OS rate than no obvious nucleoli group. IDCT patients with hematological neoplasia were typically of older age, and this group of patients had a worse prognosis. Histological feature of prominent nucleoli also has a worse prognosis.